Generic drug makerLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field. in United StatesLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field., part of Teva. FDA records under its name, each linked to the record. See the Teva group view.
As of Nov 22, 2026, FDA's public records list Actavis LLC, an indirect, wholly-owned subsidiary of Teva Pharmaceuticals U.S.A. with 1 complete response letter. The most recent is a complete response letter dated Jun 26, 2018: Complete response letter, NDA 208419.
Drug approvals, 510(k) clearances, recalls and letters, 2018 to 2026 to date
A hatched bar is a year that is not over, so its count covers only part of the year.
| Date | Record | Source |
|---|---|---|
| Jun 26, 2018 | Complete response letter, NDA 208419Approved | Complete response letter |
Spellings are joined only when they reduce to the same name, or a reviewed source names the same company. Sharing an FDA establishment number (FEI) is not enough: contract sites make products for many firms. Facts marked AI were labelled by a language model from the firm's FDA names; everything else comes from FDA or Wikidata.